Atlas Trials

Kaleido Biosciences

12 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Kaleido Biosciences

RecordFirmDate
An Observational Clinical Study to Evaluate COVID-19 Symptoms in "Long Hauler" Patients Who Participated in K031-120 or K032-120 (NCT04814914)Kaleido Biosciences2021-03-25
A Clinical Study to Assess the Physiologic Effects of KB109 in Patients With COVID-19 on Gut Microbiota Structure and Function (NCT04486482)Kaleido Biosciences2021-01-12
A Clinical Study to Assess the Natural History of COVID-19 and Effects of KB109 and Supportive Self-care in Outpatients With Mild-to-moderate COVID-19 (NCT04414124)Kaleido Biosciences2020-08-02
UNLOCKED: A Phase 2, Open-label Trial With KB195 in Subjects With a Urea Cycle Disorder (NCT03933410)Kaleido Biosciences2019-09-17
VITORA: Clinical Study to Evaluate the Effect of KB109 on the Gut Microbiome in Subjects Whose Gastrointestinal Tracts Are Colonized With Multiple Drug-resistant Organisms (NCT03944369)Kaleido Biosciences2019-06-27
Clinical Food Study to Evaluate the Effect of KB174 on the Gut Microbiome in Subjects With Well-compensated Cirrhosis (NCT03855956)Kaleido Biosciences2019-02-27
Clinical Food Study to Evaluate the Effect of KB195 on Gut Nitrogen Metabolism in Patients With Urea Cycle Disorders (NCT03797131)Kaleido Biosciences2019-01-06
A Clinical Study to Assess the Effect of Novel Glycans on Nitrogen Metabolism of the Gut in Healthy Subjects (NCT04603378)Kaleido Biosciences2017-09-18
A Clinical Study to Assess the Effect of Increasing Intake Amounts of Two Novel Glycans on the Gut Microbiota of Healthy Subjects (NCT04619875)Kaleido Biosciences2017-09-11

Track Kaleido Biosciences automatically

Every clearance here is in the API, with alerts when new ones post.